Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafusp

Authors

Toulsie Ramtohul, Xavier-Louis Jasawant, José Luis Sandoval, Léah Mailly-Giacchetti, Gaëlle Pierron, Nathalie Cassoux, Pascale Mariani, Marc-Henri Stern, Shufang Renault, Aurore Rampanou, Raphael Sanchez, Sophie Piperno-Neumann, Vincent Servois, Manuel Rodrigues